1[1]Bonduel M, Santos P, Turienzo CF, et al. Atypical skin lesions caused by Curvularia sp and Pseudallescheria boydii in two patients after allogeneic bone marrow transplantation[J]. Bone Marrow Transplant, 2001, 27(12): 1311-1313 被引量：1
2[5]Wheat LJ, Goldman M, Sarosi G. State-of-the-art review of pulmonary fungal infections[J]. Semin Respir Infect, 2002, 17(2): 158-181. 被引量：1
3[8]Koss T, Bagheri B, Zeana C, et al. Amphotericin B-resistant Aspergillus flavus infection successfully treated with caspofungin, a novel antifungal agent[J]. J Am Acad Dermatol, 2002, 46(6): 945-947. 被引量：1
4Warnock DW.Trends in the epidemiology of invasive fungal infections[J].Nippon Ishinkin Gakkai Zasshi,2007,48(1):1-12. 被引量：1
5Pfaller MA,Diekema DJ,Gibbs DL,et al.Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis:a global assessment from the ARTEMIS DISK.Antifungal Surveillance Program,2001 to 2005[J].J Clin Microbiol,2008,46(3):842-849. 被引量：1
6Agvald-Ohman C,Klingspor L,Hjelmqvist H,et al.Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit:Candida colonization index,risk factors,treatment and outcome[J].Scand J Infect Dis,2008,40(2):145-153. 被引量：1
7Chang MR,Correia FP,Costa LC,et al.Candida bloodstream infection:data from a teaching hospital in Mato Grosso do Sul,Brazil[J].Rev Inst Med Trop Sao Paulo,2008,50(5):265-268. 被引量：1
8León C,Ruiz-Santana S,Saavedra P,et al.A bedside scoring system("Candida score")for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization[J].Scand J Infect Dis,2006,34(3):730-737. 被引量：1
9Piarroux R,Grenouillet F,Balvay P,et al.Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients[J].Crit Care Med,2004,32(12):2443-2449. 被引量：1
10Colombo AL,Nucci M,Park BJ,et al.Epidemiology of candidemia in Brazil:a nationwide sentinel surveillance of candidemia in eleven medical centers[J].J Clin Microbiol,2006,44(8):2816-2823. 被引量：1
